Metabolism of branches chain aminoacids

Reading File

Finding Sources

Searching the Web

branched chain amino acid metabolism biochemistry pathway BCAA

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Finding Sources

Loading Image

I now have all the information needed for a thorough answer. Let me compile it.

Metabolism of Branched-Chain Amino Acids (BCAAs)

The BCAAs are leucine, isoleucine, and valine - all three are essential amino acids with a distinctive branched carbon side chain. They are unique among amino acids in that their catabolism occurs primarily in peripheral tissues (especially skeletal muscle), rather than in the liver.

Overview

Amino Acid	Glucogenic / Ketogenic	End Products
Valine	Glucogenic only	Succinyl CoA
Isoleucine	Both glucogenic and ketogenic	Acetyl CoA + Succinyl CoA
Leucine	Ketogenic only	Acetoacetate + Acetyl CoA

Shared Catabolic Steps (Common to All Three BCAAs)

Step 1: Transamination

The amino group of each BCAA is transferred to α-ketoglutarate, forming the corresponding branched-chain α-keto acid (BCKA) and glutamate. This reaction is catalyzed by a single enzyme, branched-chain amino acid aminotransferase (BCAT), which:

Requires vitamin B6 (pyridoxal phosphate) as coenzyme
Is expressed primarily in skeletal muscle (BCAT2 isoform)
Has low activity in the liver (unlike most other transamination reactions)

The three α-keto acids produced are:

Valine → α-ketoisovalerate
Leucine → α-ketoisocaproate
Isoleucine → α-keto-β-methylvalerate

Step 2: Oxidative Decarboxylation (Rate-limiting step)

The three BCKAs are all substrates for the branched-chain α-keto acid dehydrogenase (BCKD) complex, located in the mitochondria. This reaction:

Removes the carboxyl group and attaches CoA
Produces NADH and CO2
Is irreversible

BCKD is structurally analogous to:

Pyruvate dehydrogenase (PDH)
α-Ketoglutarate dehydrogenase

All three complexes share the same dihydrolipoyl dehydrogenase (E3) component.

Coenzymes required by BCKD:

Thiamine pyrophosphate (TPP) - vitamin B1
Lipoic acid
FAD
NAD+
Coenzyme A

Regulation of BCKD:

Inactivated by phosphorylation via BCKD kinase (BCKDK) - this is the normal resting state
Activated by dephosphorylation via phosphatase (PPM1K)
The BCKAs themselves inhibit BCKDK (thus stimulating their own oxidation - a classic product-feedback mechanism)
Insulin activates BCKD by inhibiting BCKDK

Step 3: Dehydrogenation

The CoA thioesters produced by BCKD are further oxidized to produce α-β-unsaturated acyl CoA derivatives and FADH2. These reactions are analogous to the FAD-linked dehydrogenation step in fatty acid β-oxidation.

Individual Catabolic Pathways

Valine (Glucogenic)

Valine → α-ketoisovalerate → isobutyryl CoA → methylmalonyl CoA → succinyl CoA (enters TCA cycle)

The propionyl CoA intermediate is converted to succinyl CoA via:

Propionyl CoA carboxylase (requires biotin)
Methylmalonyl CoA mutase (requires vitamin B12 as adenosylcobalamin)

Isoleucine (Glucogenic + Ketogenic)

Isoleucine → α-keto-β-methylvalerate → 2-methylbutyryl CoA → propionyl CoA + acetyl CoA

Propionyl CoA → methylmalonyl CoA → succinyl CoA (glucogenic)
Acetyl CoA is directly ketogenic

Leucine (Ketogenic only)

Leucine → α-ketoisocaproate → isovaleryl CoA → β-methylcrotonyl CoA → HMG-CoA → acetoacetate + acetyl CoA

The β-methylcrotonyl CoA carboxylase step requires biotin
Leucine is the only amino acid that is purely ketogenic (along with lysine)
Leucine is also the primary regulator of protein synthesis via mTOR pathway

End Products Summary Diagram

BCAA end products - Leucine yields acetoacetate + acetyl CoA; valine and isoleucine yield propionyl CoA → methylmalonyl CoA → succinyl CoA (with biotin/B12), and isoleucine also yields acetyl CoA

Clinical Correlations

Maple Syrup Urine Disease (MSUD)

Caused by a deficiency of the BCKD complex (any of its subunits: E1α, E1β, E2, or E3)
Results in accumulation of all three BCAAs and their toxic keto-acids in blood and urine
The keto-acids (especially α-ketoisocaproate from leucine) are responsible for the characteristic sweet/maple syrup odor
Alloisoleucine (not normally present) accumulates and is a pathognomonic marker

Labs in MSUD:

MSUD chromatography showing elevated Leu, Val, Ile, Allo-Ile in plasma and characteristic keto-acids (2KIV, 2KMV, 2KIC) in urine

Clinical features: vomiting, lethargy progressing to coma, developmental delay, ataxia, cerebral edema

Treatment: dietary restriction of BCAAs (especially leucine), acute episodes need IV mannitol, hypertonic saline, IV glucose. Liver transplantation is curative.

Isovaleric Acidemia

Deficiency of isovaleryl CoA dehydrogenase (step in leucine catabolism)
Presents with neurologic problems and a "sweaty feet" odor in body fluids (from isovalerate accumulation)

Methylmalonic Acidemia

Deficiency in methylmalonyl CoA mutase or vitamin B12 deficiency
Impairs conversion of propionyl CoA → succinyl CoA
Affects valine, isoleucine, methionine, and threonine catabolism (all generate propionyl CoA)

Physiological Roles of BCAAs

Energy substrate - particularly during exercise and fasting in skeletal muscle
Protein synthesis - BCAAs (especially leucine) activate the mTOR pathway to stimulate muscle protein synthesis
Nitrogen transport - muscle BCAT transfers nitrogen to glutamate, which can donate it to alanine (alanine cycle) or glutamine for transport to the liver/kidney
Neurotransmitter synthesis - in the brain, BCAAs provide nitrogen for synthesis of glutamate and GABA

Biochemistry, 8th ed - Lippincott Illustrated Reviews, pp. 748-752 (H. Branched-chain amino acid degradation)
Tietz Textbook of Laboratory Medicine, 7th ed, p. 2473 (MSUD chromatographic profiles)

This is a shared conversation. Sign in to Orris to start your own chat.